Alison R. Mercer-Smith

University of North Carolina at Chapel Hill

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Development of next-generation tumor-homing induced neural stem cells to enhance treatment of metastatic cancers”.

Development of next-generation tumor-homing induced neural stem cells to enhance treatment of metastatic cancers

Science Advances(2021)10.1126/sciadv.abf1526

N/A

0DataRank · unranked

19 citations

Yuchen Yang, Alison R. Mercer-Smith, Alain Valdivia, Juli R. Bagó, Alex S. Woodell +6 more

Current approaches in enhancing TRAIL therapies in glioblastoma

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad047

N/A

0DataRank · unranked

16 citations

Clara Mellows, Alison R. Mercer-Smith, Phuong L. Nguyen, Shawn Hingtgen, Morrent Thang

Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200834

N/A

0DataRank · unranked

4 citations

Clara Mellows, Lauren Kass, Sabrina Daglish, Emily M.J. Fennell, Breanna Mann +5 more

Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma

UNC Libraries(2024)10.17615/s01d-wr92

N/A

0DataRank · unranked

0 citations

Shawn Hingtgen, Clara Mellows, Lee M. Graves, Lauren Kass, Alain Valdivia +5 more